BMS, AstraZeneca Pay AWP Plaintiffs Double Damages
A federal judge has ordered AstraZeneca and Bristol-Myers Squibb to pay Massachusetts plaintiffs in the average wholesale drug price multidistrict litigation $12.9 million and $695,594, respectively, doubling the damages requested after...To view the full article, register now.
Already a subscriber? Click here to view full article